A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial.

Nat Med · 2026 · PMC12920121 · PMID 41699126

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significanceP = 0.08so close (0.05 < p ≤ 0.1)

However, this longer-term difference did not reach statistical significance ( P = 0.08).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.